{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:35Z","timestamp":1759333235619},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2007.01.032","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T06:59:14Z","timestamp":1174546754000},"page":"568-570","source":"Crossref","is-referenced-by-count":16,"title":["Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK)"],"prefix":"10.1016","volume":"69","author":[{"given":"Hamid","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2007.01.032_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004397-200604620-00005","article-title":"Herpes simplex ocular inflammatory disease","volume":"46","author":"Green","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.mehy.2007.01.032_bib2","series-title":"Ocular infection and immunity","author":"Pepose","year":"1996"},{"issue":"4","key":"10.1016\/j.mehy.2007.01.032_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","article-title":"Herpes simplex keratitis","volume":"25","author":"Kaye","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"20","key":"10.1016\/j.mehy.2007.01.032_bib4","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","article-title":"Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis","volume":"75","author":"Zheng","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.mehy.2007.01.032_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)61777-4","article-title":"Control of stromal keratitis by inhibition of neovascularization","volume":"159","author":"Zheng","year":"2001","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.mehy.2007.01.032_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4049\/jimmunol.175.1.509","article-title":"Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects","volume":"175","author":"Kim","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2007.01.032_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1358\/dnp.2002.15.6.840034","article-title":"DNA containing bioactive CpG motifs promote angiogenesis","volume":"15","author":"Klinman","year":"2002","journal-title":"Drug News Perspect"},{"issue":"13","key":"10.1016\/j.mehy.2007.01.032_bib8","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1073\/pnas.132605599","article-title":"DNA containing CpG motifs induces angiogenesis","volume":"99","author":"Zheng","year":"2002","journal-title":"Proc Nat Acad Sci USA"},{"issue":"November","key":"10.1016\/j.mehy.2007.01.032_bib9","article-title":"A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents","author":"Hosseini","year":"2006","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.mehy.2007.01.032_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery development of bevacizumab an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"December","key":"10.1016\/j.mehy.2007.01.032_bib11","article-title":"Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration","author":"Aisenbrey","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.mehy.2007.01.032_bib12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.mehy.2007.01.032_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"issue":"November","key":"10.1016\/j.mehy.2007.01.032_bib14","article-title":"Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis","author":"Jorge","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"December","key":"10.1016\/j.mehy.2007.01.032_bib15","article-title":"Inhibition of experimental corneal neovascularization by bevacizumab (Avastin)","author":"Manzano","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.mehy.2007.01.032_bib16","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T12:52:56Z","timestamp":1546951976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0306987707000977"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.01.032","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}